CABOT CORP CBT

Healthcare SIC 2890 - Miscellaneous Chemical Products NAICS Manufacturing › Chemical Manufacturing derived NYSE

Cabot is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Our principal products are reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants, and aerogel. Cabot and its affiliates have manufacturing facilities and operations in the United States ("U.S.") and over 20 other countries. Cabot's business was founded in 1882 and incorporated in the State of Delaware in 1960. The terms "Cabot", "Company", "we", and "our" as used in this report refer to Cabot Corporation and its consolidated subsidiaries.

In early fiscal 2022, we introduced our "Creating for Tomorrow" growth strategy. This strategy is focused on investing for advantaged growth, developing innovative products and processes that enable a better future, and driving continuous improvement in all we do. Our products are generally based on technical expertise and innovation in one or more of our four core competencies: making and handling very fine particles; modifying the surfaces of very fine particles to alter their functionality; designing particles to impart specific properties to a formulation; and combining particles with other ingredients to deliver a formulated performance intermediate or composite. We focus on creating particles, and formulations of those particles, with the composition, morphology, and surface functionalities to deliver the requisite performance to support our customers' existing and emerging applications.

Last close 73.79 2026-10-23
Market cap $3.81B 2026-06-30 share count
52-week range 58.33 - 94.53

Valuation FY2025 figures against the last close

P/S1.0x
P/E12.3x
P/FCF9.7x
EV/EBITDA6.0x
Dividend yield2.5%
Diluted EPS6.02

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $3.71B$3.99B$3.93B$4.32B$3.41B$2.61B$3.34B$3.24B$2.72B$2.41B
Cost of revenue $2.77B$3.03B$3.09B$3.44B$2.61B$2.11B$2.65B$2.47B$2.06B$1.84B
Gross profit $940.0M$960.0M$839.0M$885.0M$799.0M$500.0M$685.0M$772.0M$657.0M$575.0M
R&D $59.0M$63.0M$57.0M$55.0M$56.0M$57.0M$60.0M$66.0M$57.0M$53.0M
SG&A $260.0M$283.0M$253.0M$258.0M$289.0M$292.0M$290.0M$308.0M$262.0M$275.0M
Operating income $621.0M$614.0M$526.0M$389.0M$454.0M$21.0M$306.0M$144.0M$338.0M$247.0M
Interest expense $76.0M$81.0M$90.0M$56.0M$49.0M$53.0M$59.0M$54.0M$53.0M$54.0M
Pre-tax income $565.0M$529.0M$451.0M$335.0M$406.0M-$33.0M$255.0M$117.0M$299.0M$191.0M
Income tax $196.0M$111.0M$28.0M$102.0M$123.0M$191.0M$70.0M$193.0M$33.0M$33.0M
Net income $331.0M$380.0M$445.0M$209.0M$250.0M-$238.0M$157.0M-$113.0M$248.0M$147.0M
EPS, basic 6.076.797.793.654.35-4.212.64-1.853.942.34
EPS, diluted 6.026.727.733.624.34-4.212.63-1.853.912.32
Shares, diluted (wtd. avg.) 54.2M55.7M56.5M56.9M56.8M56.6M58.8M61.7M62.7M62.9M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $258.0M$223.0M$238.0M$206.0M$168.0M$151.0M$169.0M$175.0M$280.0M$200.0M
Inventory $504.0M$552.0M$585.0M$664.0M$523.0M$359.0M$466.0M$511.0M$433.0M$342.0M
Total current assets $1.54B$1.60B$1.63B$1.82B$1.43B$978.0M$1.21B$1.39B$1.30B$1.05B
Property, plant and equipment $1.71B$1.53B$1.41B$1.27B$1.38B$1.31B$1.35B$1.30B$1.30B$1.29B
Goodwill $134.0M$133.0M$134.0M$129.0M$140.0M$134.0M$45.0M$93.0M$154.0M$152.0M
Other intangibles $55.0M$53.0M$60.0M$63.0M$100.0M$103.0M$96.0M$98.0M$137.0M$140.0M
Total assets $3.81B$3.74B$3.60B$3.52B$3.31B$2.78B$3.00B$3.24B$3.34B$3.05B
Accounts payable $459.0M$495.0M$438.0M$533.0M$480.0M$316.0M$390.0M$446.0M$339.0M$259.0M
Short-term debt $260.0M$8.0M$8.0M$7.0M$373.0M$7.0M$7.0M$35.0M$256.0M$1.0M
Total current liabilities $957.0M$772.0M$822.0M$1.10B$1.15B$529.0M$599.0M$952.0M$742.0M$397.0M
Long-term debt $856.0M$1.09B$1.09B$1.09B$717.0M$1.09B$1.02B$719.0M$661.0M$914.0M
Retained earnings $1.83B$1.73B$1.57B$1.28B$1.16B$989.0M$1.34B$1.42B$1.71B$1.54B
Total equity $1.55B$1.43B$1.41B$1.03B$1.09B$814.0M$1.13B$1.28B$1.62B$1.39B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $665.0M$692.0M$595.0M$100.0M$257.0M$377.0M$363.0M$298.0M$348.0M$392.0M
Depreciation and amortisation $154.0M$151.0M$144.0M$146.0M$160.0M$158.0M$148.0M$149.0M$155.0M$161.0M
Stock-based compensation $24.0M$25.0M$20.0M$23.0M$21.0M$9.0M$11.0M$22.0M$16.0M$17.0M
Capital expenditure $274.0M$241.0M$244.0M$211.0M$195.0M$200.0M$224.0M$229.0M$147.0M$112.0M
Investing cash flow -$298.0M-$235.0M-$214.0M-$118.0M-$186.0M-$288.0M-$94.0M-$246.0M-$149.0M-$104.0M
Financing cash flow -$336.0M-$415.0M-$403.0M$145.0M-$60.0M-$132.0M-$236.0M-$141.0M-$133.0M-$184.0M
Dividends paid $96.0M$93.0M$88.0M$84.0M$80.0M$80.0M$80.0M$80.0M$77.0M$65.0M
Buybacks $168.0M$172.0M$98.0M$53.0M$3.0M$44.0M$173.0M$142.0M$61.0M$45.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-25-292412.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -2B 0 2B 4B 6B Revenue, FY2016: 2.4B Gross profit, FY2016: 575M Net income, FY2016: 147M Revenue, FY2017: 2.7B Gross profit, FY2017: 657M Net income, FY2017: 248M Revenue, FY2018: 3.2B Gross profit, FY2018: 772M Net income, FY2018: -113M Revenue, FY2019: 3.3B Gross profit, FY2019: 685M Net income, FY2019: 157M Revenue, FY2020: 2.6B Gross profit, FY2020: 500M Net income, FY2020: -238M Revenue, FY2021: 3.4B Gross profit, FY2021: 799M Net income, FY2021: 250M Revenue, FY2022: 4.3B Gross profit, FY2022: 885M Net income, FY2022: 209M Revenue, FY2023: 3.9B Gross profit, FY2023: 839M Net income, FY2023: 445M Revenue, FY2024: 4B Gross profit, FY2024: 960M Net income, FY2024: 380M Revenue, FY2025: 3.7B Gross profit, FY2025: 940M Net income, FY2025: 331M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $2.41B $2.72B $3.24B $3.34B $2.61B $3.41B $4.32B $3.93B $3.99B $3.71B
Gross profit $575.0M $657.0M $772.0M $685.0M $500.0M $799.0M $885.0M $839.0M $960.0M $940.0M
Net income $147.0M $248.0M -$113.0M $157.0M -$238.0M $250.0M $209.0M $445.0M $380.0M $331.0M

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Other event Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Material agreement terminated An agreement that mattered has ended. Often the other half of a deal that fell through. Item 1.02
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Results announced Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2890

TickerCompanyMarket capP/ERevenue growth
ESI Element Solutions Inc $8.09B 42.0x 3.8%
WDFC WD 40 CO $2.85B 31.8x 5.0%
FTK FLOTEK INDUSTRIES INC/CN/ $865.7M 28.5x 26.9%
OEC Orion S.A. $308.0M — -3.8%
ASPI ASP Isotopes Inc. $298.2M — 475.5%
FSI FLEXIBLE SOLUTIONS INTERNATIONAL INC $81.9M 106.8x 0.7%
ARQ Arq, Inc. $76.4M — 10.4%
ZTEK Zentek Ltd. — — —